Xenomics to Present the Transrenal DNA Diagnostic Technology at General Meeting of the ASM
News May 29, 2006
Xenomics, Inc. has announced that Dr. Samuil Umansky, MD, Ph.D., Xenomics' Chief Science Officer, and Co-Founder, was invited to make a presentation regarding Transrenal DNA and its potential impact on global detection of Tuberculosis and other infectious diseases at the 106th General Meeting of the American Society for Microbiology in Orlando, Florida.
Dr. Umansky's presentation titled "Detection of Transrenal Mycobacterial DNA for Diagnosis and Monitoring of Tuberculosis" was one of the featured topics in "The Clinical Frontier" portion of the ASM program devoted to new technologies.
"We were pleased to be invited by the ASM to introduce this breakthrough DNA-based diagnostic technology," said Dr. David Tomei, CEO of Xenomics.
"We intend to utilize this platform to develop and commercialize a whole new generation of completely safe, non-invasive, and highly sensitive diagnostic testing products for the detection and monitoring of wide range of infectious diseases and other conditions."
Xenomics' proprietary Transrenal DNA diagnostic technology utilizes urine samples, rather than invasive blood or other samples.
Fragmented cellular DNA from throughout the body cross the kidney barrier and accumulate in the urine providing vital information about a wide range of conditions inside the body.
The Company believes this technology will foster fundamental improvements in safety, accuracy and functionality of testing in the field of molecular diagnostics, currently a US$1.5 billion segment of the healthcare industry.
Bird and Turtle Chromosomes Help Identify Dinosaur DNANews
Researchers have used bird and turtle DNA to extrapolate the chromosome structure of their common ancestor that lived around 260 million years ago – 20 million years before the dinosaurs first emerged. They were then able to trace the evolution of avian and non-avian dinosaur DNA through to the present day.
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE
Yeast Study Performs Hundreds of Simultaneous CRISPR EditsNews
A new technique which can alter hundreds of different genes at once in baker's yeast could greatly speed up CRISPR-Cas9 editing and offer a way to perform high-throughput functional genomics.READ MORE